Information for Doctors

Are you a DOCTOR looking for more details about our practice?

Thoracic Medicine

Think you might have a breathing disorder or just looking for more information?

Sleep Medicine

Latest News

They light up our screens, perform live shows all over the world, and amaze us with their skills out on the court and in the field. It’s hard to believe that some of the most famous entertainers in the world have to deal with sleep disorders like anyone else.
  Read more...
 

Mobile Phone/TV/Laptop -  any device with a screen sends out blue wavelengths of light, which can tamper with the natural release of sleep-promoting hormone melatonin. 

Read more...
 

Bioresorbable splints used for just second time ever, successfully improved breathing so baby can go home for the first time.

Read more...
 

TSGQ's very own senior sleep scientist Jade Pittard answers the publics questions regarding sleep and how to achieve it in a recent radio segment with 612 ABC presenter Katrina Davidson.

Read more...
 

The system that allows the sharing of genetic material between bacteria – and therefore the spread of antibiotic resistance – has been uncovered by a team of scientists from UCL and Birkbeck, University of London.

Read more...
 

Dreaming may be the conscious awareness of underlying processes of offline learning and memory consolidation where the integration of this occurs during sleep.

Read more...

Current trials

Patients needed for patent 1, patent 2 and chest clinical trials

PATENT 1, PATENT 2 and CHEST trials are currently underway at the Wesley Pulmonary Hypertension Unit and new patients are required.  We are trialing Riociuguat - a direct stimulator of the soluable Guanylate Cyclase which plays a significant role in the nitric oxide pathway and is intended for the treatment of PH. The trial is in association with Bayer and Wesley Research Institute.

In PATENT 1 & 2 trials, the patient can already be on therapy with an endothelin receptor antagonists (bosentan, sitaxentan or ambrisetan) or naïve to PAH therapy.

The CHEST trial is using the same agent for non-operable chronic thromboembolic disease related PAH.  (CTEPH)

We are accepting patients now for these trials by referral.

About The Wesley Pulmonary Hypertension Unit

The Wesley Pulmonary Hypertension Unit (WPHU) has established itself as one of the largest specialised treatment centres in Queensland.  In just 18 months of operation, the clinic has reviewed patients for treatment and have been actively enrolling patients into international clinical trials.  The treatment programs include monotherapy and combination treatments in keeping with the best available therapies for PAH.

Treatments Available

All PBS funded medications for monotherapy

Combination therapy – funded or via clinical trials

Clinical Trials with WRI

PATENT 1 and 2 trials

CHEST trial

Diagnostic Procedures

Cardiac Catherterisation
Nuclear imaging
MRI and CT
Echocardiograms
Complex Lung Testing CPET
Diagnostic Sleep Studies
6 MWT


The Wesley Pulmonary Hypertension Unit multidisciplinary team includes:

Dr John Feenstra
Thoracic and Sleep Physician
P:  (07) 3876 9033
F:  (07) 3871 3222
E:  This e-mail address is being protected from spambots. You need JavaScript enabled to view it
W: www.thoracicandsleep.com.au

Dr Andrew Scott
Thoracic and Sleep Physician
P:  (07) 3876 8405
F:  (07) 3870 3212
E:   This e-mail address is being protected from spambots. You need JavaScript enabled to view it
W:  www.thoracicandsleep.com.au

Dr David Cross
Cardiologist
P:  (07) 3858 8600
F:   (07) 3870 4917
E:   This e-mail address is being protected from spambots. You need JavaScript enabled to view it
W: www.heartcarepartners.com.au

Helen Woodhouse, CNC
WPHU Coordinator
P:  0404 650 281
F:  (07) 3871 3222
E:   This e-mail address is being protected from spambots. You need JavaScript enabled to view it

© copyright 2010 | All Rights Reserved | Web Design Brisbane by iFactory